Figure 3.

Proportion of patients who received treatment intensification after a given period of time (patients managed with a defined number of OADs). ^*Total number of patients for whom treatment intensification was required. ^†HbA1c target used to define suboptimal glycaemic control in patients who required treatment intensification. ^‡Length of time to assess treatment intensification after HbA1c level was above target. ^§Consistently above HbA1c target for 1 year post diagnosis. ^||Consistently above HbA1c target for 2 years post diagnosis. HbA1c, glycated haemoglobin; OAD, oral antidiabetic drug; TI, treatment intensification